Alexandra Valenti

Alexandra Valenti

Associate
Alexandra Valenti

Alexandra Valenti, an associate in Goodwin’s Intellectual Property Litigation Group, focuses her practice on patent matters, with an emphasis on biotechnology and pharmaceuticals. Her experience also includes products liability litigation involving both pharmaceuticals and medical devices. Ms. Valenti joined Goodwin in 2012.

Experience

Erfahrung

工作经历

Ms. Valenti focuses her practice on patent matters, with an emphasis on biotechnology and pharmaceuticals. Ms. Valenti has experience representing companies in all stages of patent litigation, from pre-suit investigation through trial and appeal. Representative matters include:

  • Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc., No. 1:14-cv-05878 (D.N.J.): Representing Teva in ongoing patent litigation involving its generic Abilify® (aripiprazole) product, including defeat of a motion for preliminary injunction and temporary restraining order.
  • Tris Pharma, Inc. v. Actavis Laboratories FL, Inc.,  No. 1:14-cv-01309 (D. Del.): Representing Actavis in an ongoing patent infringement litigation filed by Tris under the Hatch-Waxman Act in response to Actavis’s filing of an abbreviated new drug application seeking approval to market a generic version of Pfizer’s ADHD product, Quillivant® (methlyphenidate).
  • Genzyme Corporation, et al. v. Teva Pharmaceuticals USA, Inc., et al., No. 1:13-cv-01506 (D. Del.): Representing Teva in an ongoing patent infringement litigation filed by Genzyme under the Hatch-Waxman Act in response to Teva’s filing of an abbreviated new drug application seeking approval to market a generic version of Genzyme’s stem cell mobilizing agent, Mozobil® (plerixafor).
  • Intendis GmbH et al. v. Glenmark Pharmaceuticals Ltd. et al., No. 1:13-cv-00421 (D. Del.): Representing Glenmark in ongoing patent infringement litigation, including trial and appeal to the Federal Circuit, filed by Intendis and Bayer based on Glenmark’s filing of an abbreviated new application seeking approval for a generic version of Bayer’s topical rosacea treatment, Finacea® (azelaic acid).
  • Momenta Pharmaceuticals, Inc. et al. v. Teva Pharmaceuticals USA, Inc., No. 14-1274 (Fed. Cir.):  Represented Teva in its successful patent infringement appeal concerning its generic version of Sanofi's Lovenox® (enoxaparin sodium) drug product.
  • Teva Branded Pharmaceutical Products R&D, Inc. et al. v. Perrigo, Inc., et al., No. 1:12-cv-01101 (D. Del.): Represented Teva Branded Pharmaceutical Products R&D, Inc. in patent litigation involving its inhaler, ProAir® HFA, the most widely prescribed albuterol sulfate metered-dose inhaler. The case was settled favorably.
Professional Activities

Ms. Valenti is a member of the New York Intellectual Property Law Association (NYIPLA). She is also a member of the Manhattan Institute’s Young Leaders Circle.

Professional Experience

Prior to joining Goodwin, Ms. Valenti was a legislative aide for Congressman Peter T. King (NY) in the U.S. House of Representatives.

Recognition

While attending law school, Ms. Valenti was selected as a member of Georgetown University Law Center’s Moot Court Team. She was a semifinalist in the 2011 NYU Immigration Law Competition and was awarded best brief. Also during law school, Ms. Valenti was the symposium editor of the Georgetown Journal of Law and Public Policy and earned CALI awards in Evidence and Church-State Law.

In The News

In den Nachrichten

在新闻中

Credentials

Anmeldeinformationen

专业资格

Education

Bildung

教育背景

J.D., 2012
Georgetown University Law Center
B.A., Physics, 2007
The George Washington University

Admissions

Zulassung

律师资格

Bar

Bar

酒吧入场

New York

Courts

Gerichte

法庭

U.S. District Court for the Southern District of New York
U.S. District Court for the Eastern District of New York
U.S. Court of Appeals for the Federal Circuit
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Search Other Lawyers

Suche Andere Rechtsanwälte

搜寻其他律师